

Pazolee 400mg Tablet (Pazopanib)
Manufactured By
Admac life science
Pack Of
30
Salt Composition
Pazopanib
Storage
Keep in cold place
Fast Delivery

Easy Returns

Secure Payments

Up to 60% Discounts
ALL SUBSTITUTES
Overview
Pazolee 400mg Tablet is an anticancer medicine with active ingredient Pazopanib. It is a second-generation multi targeted tyrosine kinase inhibitor. Doctor prescribed Pazolee to treat metastatic soft tissue sarcoma and kidney cancer.
It works by acting against protein known as Vascular Endothelial Growth Factors (VEGF) to control the growth and spread of the cancer cells. Take it as prescribed by the doctor at fix time each day to get better results.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | pazolee |
| Generic / Active Ingredient | Pazopanib |
| Strength | 400 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | admac life science |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | kidney cancer |
Uses and Indications
Kidney Cancer
Side Effects of Pazolee 400mg Tablet
Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects. In that case, the patient should contact the doctor immediately.
Some common side effects of Pazolee 400mg Tablet(Pazopanib 400mg) include:
● Hypertension
● Hair color change
● Increased glucose levels
● Decreased weight, decrease in appetite
● Diarrhea
● Nausea, vomiting
● Muscle and joint pain
● Headache
● Shortness of breath
● Tiredness
Pazolee 400mg Tablet Dosage and How To Take It
The Dosage of the tablet is usually decided by the doctor based on the health condition of the patient. Pazolee 400mg Tablet(Pazopanib 400mg) should be taken on empty stomach at the same time every day. Take this drug as prescribed by the doctor. Swallow tablet as a whole with water and don't chew, break, or crush it.
Safety Advice for Pazolee 400mg Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking Pazolee 400mg Tablet(Pazopanib 400mg), as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
- ● Pregnancy: Do not take the Pazolee 400mg Tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
- ● Breastfeeding: Pazolee 400mg Tablet(Pazopanib 400mg) is unsafe to use during breastfeeding as it may cause toxicity to the baby.
- ● Driving: Pazolee 400mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Consumption of Pazolee 400mg Tablet(Pazopanib 400mg) should be avoided without informing the doctor if you have any kidney-related issues.
- ● Liver: Consumption of Pazolee 400mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
FAQs About Pazolee 400mg Tablet
What is Pazolee 400mg Tablet(Pazopanib 400mg) used for?
Pazolee 400mg Tablet is used in the treatment of renal cell carcinoma (kidney cancer). It is also prescribed to treat metastatic soft tissue sarcoma.
How to use Pazolee 400mg Tablet?
Take Pazolee 400mg Tablet(Pazopanib 400mg) on an empty stomach at the same time every day. Take this drug as per the prescription by your doctor.
What happens if I overdose on Pazolee 400mg Tablet?
If you overdose on Pazolee 400mg Tablet, you may feel symptoms like difficulty breathing, nausea, and chest pain. Consult your doctor if your condition worsens eventually.
Is it safe to use Pazolee 400mg during pregnancy?
Do not take Pazolee 400mg Tablet(Pazopanib 400mg) during pregnancy. This drug may cause harm to the fetus.
References
● Lee, A. T., Jones, R. L., & Huang, P. H. (2019). Pazopanib in advanced soft tissue sarcomas. Signal transduction and targeted therapy, 4(1), 16.
● Schutz, F. A., Choueiri, T. K., & Sternberg, C. N. (2011). Pazopanib: Clinical development of a potent anti-angiogenic drug. Critical reviews in oncology/hematology, 77(3), 163-171.
● Pick, A. M., & Nystrom, K. K. (2012). Pazopanib for the treatment of metastatic renal cell carcinoma. Clinical therapeutics, 34(3), 511-520.
● Sonpavde, G., & Hutson, T. E. (2007). Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Current oncology reports, 9(2), 115-119.
● Bukowski, R. M., Yasothan, U., & Kirkpatrick, P. (2010). Pazopanib. Nature reviews Drug discovery, 9(1), 17-18.
Marketer Details
Admac life science
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.















